REGENOSINE, INC
Regenosine is developing a first-in-class disease-modifying regenerative therapy for osteoarthritis.
REGENOSINE, INC
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2018-01-01
Address:
New Jersey, Saint Patrick, Trinidad And Tobago
Country:
Trinidad And Tobago
Website Url:
http://www.regenosine.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
1.67 M USD
Founder
Investors List
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) investment in Grant - Regenosine, Inc
Creative Destruction Lab (CDL)
Creative Destruction Lab (CDL) investment in Pre Seed Round - Regenosine, Inc
Official Site Inspections
http://www.regenosine.com
- Host name: a16e665f42988324c.awsglobalaccelerator.com
- IP address: 13.248.243.5
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Regenosine, Inc"
Regenosine
Regenosine is developing a first-in-class, disease-modifying regenerative therapy for osteoarthritis (OA) and other indications with unmet clinical needs utilizing a proprietary liposomal …See details»
Regenosine - Crunchbase Company Profile & Funding
Regenosine is a healthcare center that provides products that include regenerating cartilage and joint preservation. An online inquiry form is …See details»
Team - Regenosine
Dr. Bruce Cronstein was the first to discover the anti-inflammatory effects of adenosine and its role in wound healing, maintaining cartilage homeostasis, and treating OA. He is the 2013 recipient of the Lee Howley Prize for Research in …See details»
Technology - Regenosine
We are focused on developing and commercializing first-in-class musculoskeletal regenerative therapies for osteoarthritis. Our proprietary platform technology harnesses the healing …See details»
Regenosine Company Profile 2024: Valuation, Funding …
Developer of regenerative therapies technology designed to help in tissue regeneration. The company's therapies use a purinergic system that regulates …See details»
Regenosine - LinkedIn
Privately held company focused on developing and marketing first-in-class regenerative therapies for osteoarthritis. Our proprietary platform technology harnesses the healing potential of the...See details»
Regenosine - Overview, News & Similar companies | ZoomInfo.com
View Regenosine (www.regenosine.com) location in New Jersey, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Regenosine - Technology Opportunities & Ventures by NYU and …
Regenosine is developing and commercializing first-in-class musculoskeletal regenerative therapies. Its proprietary platform technology harnesses the healing potential of the purinergic …See details»
Regenosine, Inc. | VentureRadar
Website: https://regenosine.com/ Develops a pioneering regenerative therapy for osteoarthritis using injectable slow-release adenosine to regenerate cartilage and potentially delay joint …See details»
Regenosine - Products, Competitors, Financials, Employees, …
Regenosine specializes in regenerative medicine, focusing on developing therapies for osteoarthritis within the biotechnology sector. The company offers a proprietary liposomal …See details»
Regenosine Company Profile - Office Locations, Competitors, …
Regenosine is a company developing and marketing regenerative therapies for osteoarthritis. It offers a purinergic system that regulates and maintains tissue homeostasis and restores …See details»
Regenosine - Contacts, Employees, Board Members, Advisors
Regenosine is developing a disease-modifying regenerative therapy for osteoarthritis.See details»
Regenosine - Funding, Financials, Valuation & Investors
Regenosine is developing a disease-modifying regenerative therapy for osteoarthritis.See details»
RePORT 〉 RePORTER - National Institutes of Health
Regenosine is developing Lipo-Ade, a first-in-class liposomal adenosine product in a proprietary, novel formulation for effective, prolonged treatment and for regenerating cartilage in joints in …See details»
Regenosine, Inc. - Creative Destruction Lab
Regenosine is developing a first-in-class disease-modifying regenerative therapy for osteoarthritis. Its injectable slow-release adenosine formulation regenerates the articular cartilage and …See details»
Regenosine
Please contact us directly with any questions, comments, or scheduling inquiries you may have.See details»
Molecular Therapy for Tissue Regeneration With Regenosine
Regenosine is developing first-in-class therapies for tissue regeneration. The purinergic system regulates and maintains tissue homeostasis. They have demonstrated that restoring …See details»
RePORT 〉 RePORTER
Regenosine is developing Lipo-Ade, a first-in-class liposomal adenosine product in a proprietary, novel formulation for effective, prolonged treatment and for regenerating cartilage in joints in …See details»
Regenosine, Inc. - VentureRadar
Website: https://regenosine.com/ Develops a pioneering regenerative therapy for osteoarthritis using injectable slow-release adenosine to regenerate cartilage and potentially delay joint …See details»
NEWS - Regenosine
Oct 11, 2023 · Regenosine is proud to be selected as one of the 60 featured companies at the 2024 Mid-Atlantic Capital Conference presented by the Philade... Regenosine, Inc. CEO and …See details»